Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Mosaic ImmunoEngineering Inc. (CPMV : OTC)
 
 • Company Description   
Mosaic ImmunoEngineering Inc. is a development-stage biotechnology company. It is focused on bridging immunology and engineering to develop novel immunotherapies to treat and prevent cancer and infectious diseases. The company's product pipeline includes MI-O-101. Mosaic ImmunoEngineering Inc., formerly known as Patriot Scientific Corporation, is based in NOVATO, CA.

Number of Employees: 7

 
 • Price / Volume Information   
Yesterday's Closing Price: $1.20 Daily Weekly Monthly
20 Day Moving Average: 642 shares
Shares Outstanding: 7.23 (millions)
Market Capitalization: $8.67 (millions)
Beta: 1.52
52 Week High: $3.00
52 Week Low: $0.50
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 66.53% 87.54%
12 Week 71.43% 88.45%
Year To Date 17.65% 43.75%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
1537 SOUTH NOVATO BOULEVARD SUIT 5
-
NOVATO,CA 94947
USA
ph: 657-208-0890
fax: 760-547-2705
info@mosaicie.com http://www.mosaicie.com
 
 • General Corporate Information   
Officers
Steven King - President and Chief Executive Officer; Director
Paul Lytle - EVP; Chief Financial Officer; Director
Nicole Steinmetz - Acting Chief Scientific Officer; Director
Robert Baffi - Director
Gloria Felcyn - Director

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 61945M101
SIC: 2836
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/02/22
Share - Related Items
Shares Outstanding: 7.23
Most Recent Split Date: 12.00 (0.00:1)
Beta: 1.52
Market Capitalization: $8.67 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/02/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: 26.67%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
03/31/22 - -
12/31/21 - -
09/30/21 - -
ROA
03/31/22 - -846.02
12/31/21 - -929.72
09/30/21 - -741.72
Current Ratio
03/31/22 - 0.15
12/31/21 - 0.12
09/30/21 - 0.23
Quick Ratio
03/31/22 - 0.15
12/31/21 - 0.12
09/30/21 - 0.23
Operating Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Net Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Pre-Tax Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Book Value
03/31/22 - -0.47
12/31/21 - -0.39
09/30/21 - -0.30
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Capital
03/31/22 - -
12/31/21 - -
09/30/21 - -
 

Powered by Zacks Investment Research ©